August 19, 2021 | Yahoo! The companies signed an agreement for the distribution of advanced medical cannabis-based products in Poland. First sales are expected during H1
July 29, 2021 | MarketWatch TEL AVIV, Israel and BIELEFELD, Germany, July 29, 2021 /PRNewswire via COMTEX/ — TEL AVIV, Israel and BIELEFELD, Germany, July 29,
June 21 2021 | Benzinga by Jelena Martinovic Israel’s largest manufacturer and home-delivery distributor of medical cannabis products, Panaxia Labs Israel Ltd., and its German partner Neuraxpharm received the green
May 31 2021 | Yahoo! 62% growth over the corresponding period the previous year and 16% over the previous quarter; The company is currently focused on
May 19 2021 | Yahoo! Following a successful launch at the local markets in Germany, France, and Cyprus, Panaxia’s medical cannabis-based products will be distributed in
May 3 2021 | Globes Panaxia Israel is selling its pharmacy, one of Israel’s largest for cannabis products, to IMC for NIS 20 million. Six months
April 12, 2021 | Market Watch LOD, Israel, April 12, 2021 /PRNewswire/ — The Israeli subsidiary of Panaxia Global, Panaxia Labs Israel Ltd. (“Panaxia Israel”) (TASE: PNAX), Israel’s largest manufacturer of
Since November of 2020, any Israeli company wishing to export cannabis has first been required to work with Panaxia.By IDAN ZONSHINE April 15, 2021 | JPost As
Panaxia Israel Laboratories expands into EU marketplace despite challenges posed by year of COVID-19.By MAAYAN JAFFE-HOFFMAN April 5, 2021 | JPost A first shipment of Israeli medical cannabis products
At the end of Q4/2020, Panaxia began commercial exports to Germany, Europe’s largest and fastest-growing cannabis market, and in Q1/2021 was selected and began to